Table 1.
Procedure type | Screening | Enrolment | Periodontal examination | Preconception | 9–12 weeks gestation | Delivery* | Postpartum |
Specimen collection | |||||||
Urine pregnancy test | X | X | X | ||||
Genital swabs | |||||||
APTIMA swab | X | ||||||
Push-off swabs† | X | X | X | ||||
Cotton and Dacron swabs | X | X | X | ||||
Sialidase test swab | X | X | |||||
Fetal membrane swab | X | ||||||
Placental punch | X | ||||||
Fetal membrane roll | X | ||||||
Umbilical cord | X | ||||||
Laboratory testing | |||||||
HIV rapid test | X | ||||||
Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis | X | ||||||
Cervical Gram stain | X | ||||||
Vaginal pH | X | ||||||
Vaginal wet mount | X | ||||||
Vaginal Gram stain | X | X | X | ||||
Lactobacillus culture‡ | X | X | X | ||||
Sialidase test | X | X | |||||
PSA test | X | X | X | ||||
Participant Questionnaires | |||||||
Eligibility screen | X | ||||||
Demographics | X | ||||||
Reproductive history | X | ||||||
Medical history and current symptoms | X | X | X | ||||
Sexual behaviour | X | X | X | ||||
Substance use | X | X | X | ||||
Dental health history | X | ||||||
Neonatal heath | X | ||||||
Obstetric ultrasound | X |
*Delivery follows standard obstetrical procedure and is not conducted by study staff.
†Storing for vaginal microbiota and vaginal inflammatory response testing.
‡Rogosa agar, followed by subculture for hydrogen peroxide production on tetramethylbenzidine agar containing horseradish peroxidase.
PSA, prostate specific antigen.